Qu Biologics has developed a transformative first-in-class immunotherapy platform, Site Specific Immunomodulators (SSIs), that arms our first line of defense against infectious and non-infectious threats. SSIs are uniquely positioned to be implemented at the time of first emergence of a…
Tag